EIP
BIO icon

Easterly Investment Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History

Easterly Investment Partners’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,060
Closed -$367K – 202
2024
Q1 		$367K Sell
1,060
-15,597
-94% -$5.13M 0.03% 186
2023
Q4 		$5.38M Sell
16,657
-18,070
-52% -$5.66M 0.58% 64
2023
Q3 		$12.4M Sell
34,727
-9,319
-21% -$3.6M 1.37% 17
2023
Q2 		$16.7M Buy
44,046
+2,919
+7% +$1.19M 1.48% 16
2023
Q1 		$19.7M Sell
41,127
-28,350
-41% -$13.3M 1.73% 8
2022
Q4 		$29.2M Buy
69,477
+16,419
+31% +$6.63M 2.52% 2
2022
Q3 		$22.1M Buy
53,058
+3,601
+7% +$1.8M 2.12% 8
2022
Q2 		$24.5M Buy
49,457
+13,678
+38% +$7.12M 2.18% 6
2022
Q1 		$20.2M Buy
35,779
+33,907
+1,811% +$20.4M 1.52% 18
2021
Q4 		$1.41M Buy
1,872
+32
+2% +$23.9K 0.1% 126
2021
Q3 		$1.37M Hold
1,840
– – 0.09% 128
2021
Q2 		$1.19M Hold
1,840
– – 0.14% 57
2021
Q1 		$1.05M Hold
1,840
– – 0.13% 53
2020
Q4 		$1.07M Sell
1,840
-1,418
-44% -$808K 0.15% 51
2020
Q3 		$1.68M Sell
3,258
-9
-0.3% -$4.56K 0.07% 42
2020
Q2 		$1.48M Sell
3,267
-103,146
-97% -$45.5M 0.07% 43
2020
Q1 		$37.3M Sell
106,413
-57,745
-35% -$21.2M 1.65% 26
2019
Q4 		$60.7M Sell
164,158
-108,996
-40% -$38.4M 1.71% 27
2019
Q3 		$90.9M Sell
273,154
-368,654
-57% -$120M 2.55% 17
2019
Q2 		$201M Buy
641,808
+55,191
+9% +$16.5M 5.04% 1
2019
Q1 		$179M Buy
+586,617
New +$158M 4.33% 6

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Easterly Investment Partners's BIO Position: Q2 2024 in Review

Easterly Investment Partners sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2024, closing a stake of 1,060 shares — an estimated $367K sold.

Easterly Investment Partners first reported a position in BIO in Q1 2019 and held it in 21 quarters. The position peaked at $201M in Q2 2019. 440 funds tracked by Wall St. Rank hold BIO as of Q2 2024.

  • Easterly Investment Partners reported no remaining Bio-Rad Laboratories Class A position as of Q2 2024 after selling out during the quarter.
  • Easterly Investment Partners sold 1,060 Bio-Rad Laboratories Class A shares in Q2 2024, an estimated $367K.
  • Easterly Investment Partners first reported a position in Bio-Rad Laboratories Class A in Q1 2019 and held it in 21 quarters.
  • Easterly Investment Partners's Bio-Rad Laboratories Class A position peaked at $201M in Q2 2019.
  • 440 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2024.

Based on Easterly Investment Partners's 13F filing for Q2 2024, filed 25 Jul 2024.